Medical News

RSS

Itech Medical displays Muscle Pattern Recognition tool at BioContact Quebec 2009

iTech Medical, Inc. (OTCBB: IMSU) (FWB: 0IM), an information technology company, showcased the Company’s proprietary information technology platform, Muscle Pattern Recognition (MPR), at BioContact Quebec 2009.

13 Oct 2009

Amsterdam Molecular Therapeutics' AMT-080 granted EMEA Orphan Drug Designation

Amsterdam Molecular Therapeutics, a leader in the field of human gene therapy, announced today that the European Medicines Agency has granted Orphan Drug Designation to AMT's gene therapy product AMT-080 for the treatment of Duchenne muscular dystrophy.

13 Oct 2009

Merck KGaA's Indian subsidiary acquires Bangalore Genei

Merck KGaA announced today the acquisition of Bangalore Genei (India) Private Ltd. (BGIP) by its wholly owned subsidiary in India, Merck Specialities Private Ltd., from the Sanmar Group. By combining BGIP's activities with Merck's existing bioscience business, Merck will become one of the leading bioscience companies in India.

13 Oct 2009

Patient outcomes better in highly rated hospitals than others

The largest annual study of patient outcomes at each of the nation's 5,000 nonfederal hospitals found a wide gap in quality between the nation's best hospitals and all others. According to the study, issued today by HealthGrades, the leading independent healthcare ratings organization, patients at highly rated hospitals have a 52 percent lower chance of dying compared with the U.S. hospital average, a quality chasm that has persisted for the last decade even as mortality rates, in general, have declined.

13 Oct 2009

NIH funds the University of California's consortium for immune disorder research

The University of California, San Francisco has been designated to lead a new consortium that will study a group of severe immune disorders known as primary immunodeficiencies and aims to improve treatment for these often life-threatening diseases. The Primary Immune Deficiency Treatment Consortium comprises 13 centers throughout the United States and has a $6.25 million funding commitment over five years from the National Institutes of Health.

13 Oct 2009

Report on health plan performance related to tobacco cessation strategies

Tobacco cessation is one of the most cost-effective activities an employer can implement to improve the health and productivity of their employees while reducing health care costs.

13 Oct 2009

Debiopharm Group and Ipsen complete European decentralised registration of Decapeptyl

Debiopharm Group (Debiopharm), a Swiss-based global biopharmaceutical group of companies with a focus on the development of prescription drugs that target unmet medical needs, and Ipsen (Euronext: FR0010259150; IPN), an innovation-driven global specialty pharmaceutical Group, announced that the 6-month sustained-release formulation of Decapeptyl®1 (triptorelin embonate2 22.5 mg) successfully completed its European decentralised registration procedure involving nine countries: Germany (reference member state), France, Austria, Finland, Norway, Belgium, Denmark, Spain and The Netherlands.

13 Oct 2009

New RNA repair and modification system in bacteria discovered

In new papers appearing this month in Science and the Proceedings of the National Academy of Sciences, University of Illinois biochemistry professor Raven H. Huang and his colleagues describe the first RNA repair system to be discovered in bacteria.

13 Oct 2009

Phyton Biotech purchases NPI’s assets

Phyton Biotech, LLC (Phyton), an affiliate of Phyton, Inc., today announced that it has purchased the assets of Natural Pharmaceuticals, Inc. (NPI), a leading manufacturer of oncology drug active pharmaceutical ingredients (API’s).

13 Oct 2009

Premier Purchasing Partners awards new agreements for blood bank analyzers

Premier Purchasing Partners, LP, today announced new agreements for blood bank analyzers, reagents, consumables and service have been awarded to Biotest Diagnostics Corporation of Rockaway, N.J.; and Johnson & Johnson Health Care Systems Inc. of Piscataway, N.J., contracting on behalf of Ortho-Clinical Diagnostics, Inc. of Raritan, N.J.

13 Oct 2009

Central DuPage Hospital to test new device that may reverse brain damage up to 24 hours after stroke

Central DuPage Hospital, in Winfield, Ill., is the only Illinois hospital that will participate in a national investigational trial to test the effectiveness of a device that might extend the traditional stroke treatment window from three hours to an unprecedented 24 hours.

13 Oct 2009

Kidney Care Partners commends CBC for supporting reforms to improve access to quality kidney care

Kidney Care Partners - an alliance of patient advocates, dialysis professionals, care providers and manufacturers working together to improve quality of care for individuals with kidney disease and kidney failure - today applauded the Congressional Black Caucus (CBC) for supporting reforms that will improve patient access and choice in receiving quality kidney care.

13 Oct 2009

New Jersey's hospitals fuel local and state economies despite recession

Even as the economy continues to struggle, one industry in New Jersey remains a strong vital resource - New Jersey's hospitals. In 2008, the state's 73 acute care hospitals contributed 145,000 jobs and $18 billion in spending that fueled local and state economies, according to a new report from the New Jersey Hospital Association.

13 Oct 2009

VitalProteinRx nutritional supplement for chronic kidney disease affected patients

VitalRemedyMD, a physician-established company, offers scientifically formulated integrative nutritional supplements designed to improve the quality of traditional healthcare. "We are proud that VitalProteinRx is now an integral part of Fresenius' armamentarium in helping patients with chronic kidney disease," stated Dr. Seth Baum, Founder of VitalRemedyMD.

13 Oct 2009

Mechanism by which gene associated with autism and schizophrenia influences behavior identified

A Stanford University School of Medicine researcher has pinpointed the mechanism by which a gene associated with both autism and schizophrenia influences behavior in mice. And just recently, he received a $1.65 million government grant to expand his efforts to include many more such genes.

13 Oct 2009

Data Advantage releases the Top 100 Hospital: Best in Value Hospitals list

Data Advantage, LLC announced today the Top 100 Hospital: Best in Value Hospitals™ list from the 2009-2010 Hospital Value Index™, the first and only national study on U.S. hospitals and the value of care they provide.

13 Oct 2009

Despite economic downturn, Senior Living Residences marches ahead

Boston-based Senior Living Residences (SLR), a company with a 15-year history of successful ownership, lease-up and management of senior housing communities, has further burnished its track record of robust lease-up of new assisted living facilities even as other companies in the senior housing industry are reporting the negative impact of the current economic downturn.

13 Oct 2009

Varian offers new hardware and accessory options for 710-ES Series ICP-OES instruments

Varian, Inc. announced today a series of productivity enhancements for its 710-ES Series of ICP-OES (Inductively Coupled Plasma - Optical Emission Spectrometer) instruments.

13 Oct 2009

Increasing number of pre-term infants experience eye disorders

As more extremely pre-term infants survive in Sweden, an increasing number of babies are experiencing vision problems caused by abnormalities involving the retina, according to a report in the October issue of Archives of Ophthalmology, one of the JAMA/Archives journals.

13 Oct 2009

Phone-based counseling can help teen smokers to quit

For the first time, researchers at Fred Hutchinson Cancer Research Center have demonstrated that it is possible to successfully recruit and retain a large number of adolescent smokers from the general population into a smoking intervention study and, through personalized, proactive telephone counseling, significantly impact rates of six-month continuous quitting.

13 Oct 2009

Medical News

Itech Medical displays Muscle Pattern Recognition tool at BioContact Quebec 2009

Amsterdam Molecular Therapeutics' AMT-080 granted EMEA Orphan Drug Designation

Merck KGaA's Indian subsidiary acquires Bangalore Genei

Patient outcomes better in highly rated hospitals than others

NIH funds the University of California's consortium for immune disorder research

Report on health plan performance related to tobacco cessation strategies

Debiopharm Group and Ipsen complete European decentralised registration of Decapeptyl

New RNA repair and modification system in bacteria discovered

Phyton Biotech purchases NPI’s assets

Premier Purchasing Partners awards new agreements for blood bank analyzers

Central DuPage Hospital to test new device that may reverse brain damage up to 24 hours after stroke

Kidney Care Partners commends CBC for supporting reforms to improve access to quality kidney care

New Jersey's hospitals fuel local and state economies despite recession

VitalProteinRx nutritional supplement for chronic kidney disease affected patients

Mechanism by which gene associated with autism and schizophrenia influences behavior identified

Data Advantage releases the Top 100 Hospital: Best in Value Hospitals list

Despite economic downturn, Senior Living Residences marches ahead

Varian offers new hardware and accessory options for 710-ES Series ICP-OES instruments

Increasing number of pre-term infants experience eye disorders

Phone-based counseling can help teen smokers to quit

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Latest News